| Financial Year |
March 31 2023 |
| Monetary Funds |
1,668,801,366.91 |
| Held-for-trading Financial Assets |
351,685,617.50 |
| Notes Receivable |
-- |
| Accounts Receivable |
633,184,616.37 |
| Advances to Suppliers |
8,369,667.65 |
| Other Receivables |
482,835.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
787,503,946.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,030,867.66 |
| Total Current Assets |
4,236,686,081.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
902,033,305.44 |
| Under-construction Projects |
298,021,643.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
73,182,436.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,887,277.52 |
| Deferred Income Tax Assets |
14,428,650.46 |
| Other Non-Current Assets |
1,926,247.96 |
| Sub-Total of Non-Current Assets |
1,299,079,295.68 |
| Total Assets |
5,535,765,377.05 |
| Short-Term Loans |
314,039,825.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
731,063,829.18 |
| Accounts Payable |
586,673,808.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,064,575.74 |
| Taxes Payable |
61,777,846.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,964,592.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,675,248.77 |
| Other Current Liabilities |
31,122,115.15 |
| Sub-Total of Current Liabilities |
1,770,110,331.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
40,395,471.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,923,814.04 |
| Total Liabilities |
1,814,034,145.37 |
| Paid-In Capital(Or Share Stock) |
332,241,440.00 |
| Capital Surplus |
1,937,143,166.58 |
| Surplus Reserve |
149,374,284.78 |
| LESS:Treasury Stock |
66,363,516.56 |
| Undistributed Profits |
1,362,026,866.52 |
| Minority Stockholder's Interest |
5,761,381.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,715,969,849.85 |
| Owner's Equity（Stockholder's Equity） |
3,721,731,231.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,535,765,377.05 |
